Occlusal Splint and Exercise Therapy for Temporomandibular Disorders

March 27, 2026 updated by: Helin Yavuz, Acibadem University

The Effects of Occlusal Splint and Exercise in Individuals With Temporomandibular Disorders

The goal of this clinical trial is to learn if an exercise protocol can improve temporomandibular pain, jaw function and muscle mechanical properties in individuals with Temporomandibular Disorders (TMD). This study focuses on patients who are already receiving occlusal splint therapy.

The main question it aims to answer is:

How does the addition of an exercise protocol to occlusal splint therapy affect temporomandibular pain, jaw function and muscle mechanical properties of the masticatory and neck muscles? Researchers will compare the group receiving both occlusal splint therapy and the exercise protocol to a group only occlusal splint therapy to see if the combined approach is more effective.

Participants will:

  • Undergo an initial assessment of the Jaw Functional Limitation Scale-20 (JLFS-20), Craniofacial Pain and Disability Inventory (CF-PDI), Graded Chronic Pain Scale Version 2.0 (GCPS-2.0), jaw range of motion, pain pressure threshold and muscle mechanical properties.
  • Receive occlusal splint therapy as a part of their treatment.
  • Perform a structured exercise protocol (only 1 group)
  • Attend follow up sessions at the 4th week to monitor changes in all initial assessment parameters.

Study Overview

Status

Recruiting

Detailed Description

This research will be conducted as a randomized controlled, two-arm, prospective clinical trial. The study will evaluate the effects of occlusal splint application combined with the Rocabado exercise protocol in individuals with TMD. The intervention period will last for 4 weeks, with assessments conducted at baseline and at the end of the 4 weeks period.

Literature indicates that occlusal splint therapy and specialized exercise protocols are beneficial in improving symptoms in individuals with temporomandibular disorders (TMD). Studies have demonstrated that these interventions can enhance functionality and alleviate pain. However, there is a lack of research specifically comparing the combination of an occlusal splint and an exercise protocol against splint therapy alone, particularly regarding their effects on pain, functionality, and the mechanical properties of the masticatory and neck muscles.

Participants diagnosed with TMD will be recruited from two clinics in Turkey. To prevent potential imbalances, participants will be divided into two groups using stratification (age, gender, and occupation) and block randomization:

  • Splint Group (S Group): Will receive nightly occlusal splint therapy only.
  • Exercise and Splint Group (ES Group): Will receive the Rocabado 6x6 exercise protocol in addition to nightly occlusal splint therapy.

In the ES group, the occlusal splint and Rocabado exercises (6 times daily, 6 repetitions each) will be performed 7 days a week for 4 weeks. The control (S) group will utilize only the occlusal splint for the same duration.

Evaluations will be performed at baseline and at the 4th week. Clinical assessments will include the Jaw Functional Limitation Scale-20 (JFLS-20), Craniofacial Pain and Disability Inventory (CF-PDI), and Graded Chronic Pain Scale (GCPS) 2.0. Additionally, temporomandibular joint range of motion (ROM), pressure pain threshold (PPT), and mechanical muscle properties (MyotonPRO) will be assessed.

Inclusion criteria

  • Clinical and radiological diagnosis of TMD
  • Being between 18-65 years of age,
  • Presence of temporomansibular joint (TMJ) pain for the last 3 months. Exclusion criteria
  • İntra-articular or degenerative joint disorders and subluxation requiring immediate treatment,
  • A history of TMJ or cervical region surgery in the last 3 months,
  • A history of treatment from related regions,
  • The presence of rheumatic diseases, including TMJ diseases,
  • TMJ instability or fracture,
  • The presence of perception-cognition disorder,
  • The presence of chronic pain, such as trigeminal neuralgia.

Study Type

Interventional

Enrollment (Estimated)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Tuzla
      • Istanbul, Tuzla, Turkey (Türkiye), 34947
        • Recruiting
        • Okan University- Dental Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Clinical and radiological diagnosis of TMD
  • Being between 18-65 years of age
  • Presence of Temporomandibular Joint (TMJ) pain for the last 3 months.

Exclusion Criteria:

  • Intra-articular or degenerative joint disorders and subluxation requiring immediate treatment,
  • A history of TMJ or cervical region surgery in the last 3 months,
  • A history of treatment from related regions,
  • The presence of rheumatic diseases, including TMJ diseases,
  • TMJ instability or fracture,
  • The presence of perception-cognition disorder,
  • The presence of chronic pain, such as trigeminal neuralgia.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Splint Group (S Group)
S Group will receive nightly occlusal splint therapy only.
Participants will be provided with custom-made hard acrylic occlusal splints. They will be instructed to wear the appliance every night during sleep for a period of four consecutive weeks. A licensed dentist will manage the delivery and occlusal adjustment of the splints to ensure they were correctly seated and well-tolerated by the subjects. Both groups will receive a occlusal splint to be worn every night.
Experimental: Exercise and Splint Group (ES Group)
ES Group will receive the Rocabado exercise protocol in addition to nightly occlusal splint therapy.
Participants will be provided with custom-made hard acrylic occlusal splints. They will be instructed to wear the appliance every night during sleep for a period of four consecutive weeks. A licensed dentist will manage the delivery and occlusal adjustment of the splints to ensure they were correctly seated and well-tolerated by the subjects. Both groups will receive a occlusal splint to be worn every night.
Participants will perform the Rocabado 6x6 exercise protocol, which consists of six specific movements designed to restore proper tongue position, improve jaw mobility, and stabilize the craniomandibular relationship. Each exercise will be performed 6 times per session, 6 times a day. The protocol includes: Rest position of the tongue, shoulder posture, stabilized head flexion, axial extension of the neck, control of TMJ rotation and rhythmic stabilization technique. The program consists of performing 6 specific exercises, 6 times per day with 6 repetitions each, for 4 weeks.
Other Names:
  • Rocabado Exercises

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Jaw Range of Motion
Time Frame: Baseline and 4 weeks after start of treatment
Pain-free opening, maximum unassisted opening, maximum assisted opening, lateral and protrusive movements will be mesured by a ruler. All measurements will be noted in milimeters between the incisal edges of upper and lower central incisors. The average of the 3 repetitions will be taken.
Baseline and 4 weeks after start of treatment
Pain Pressure Threshold
Time Frame: Baseline and 4 weeks after start of treatment
PPT will be evaluated using a digital algometer. After positioning the algometer's rubbet tip pressure will be applied gradually. Measurements will be taken from the belly of the muscles (bilaterally for the masseter, temporalis, sternocleidomastoid and trapezius). The measurements will be made in three repetitions and the average will be noted in kg/cm2.
Baseline and 4 weeks after start of treatment
Muscle Mechanical Properties
Time Frame: Baseline and 4 weeks after start of treatment
Muscle mechanical properties will be evaluated by the MyotonPRO (Myoton AS, Tallinn, Estonia) device. Device will perform 5 measurements by 15-seconds intervals and the mean values will be recorded. Measurements will be taken from the belly of the muscles (bilaterally masseter, temporalis, sternocleidomastoid and trapezius).
Baseline and 4 weeks after start of treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Jaw functional limitation scale - 20
Time Frame: Baseline and 4 weeks after start of treatment
JLFS-20 will be used to evaluate functional limitations of the jaw. It consists of 20-items and each item scored between 0 (no limitation) to 10 (severe limitaiton) score.
Baseline and 4 weeks after start of treatment
Craniofacial Pain and Disability Inventory
Time Frame: Baseline and 4 weeks after start of treatment
Craniofacial pain and disability inventory will be used to evaluate TMD-related pain, neck pain, headache and ear pain. It consist of 21 items and each scored on a 4-point Likert-scale ranging from 0 ('no problem') to 3 ('maximum problem') score.
Baseline and 4 weeks after start of treatment
Graded chronic pain scale version 2.0
Time Frame: Baseline and 4 weeks after start of treatment
Graded chronic pain scale version 2.0 will be used to evaluate pain intensity and pain-related disability over the last 30 days. Chronic pain is graded from grade 1 (indicating low intensity pain-low disability) to grade 4 (indicating high disability-severly limiting).
Baseline and 4 weeks after start of treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Helin Yavuz, Physiotherapist, Acibadem University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 10, 2025

Primary Completion (Estimated)

July 10, 2026

Study Completion (Estimated)

July 10, 2026

Study Registration Dates

First Submitted

March 27, 2026

First Submitted That Met QC Criteria

March 27, 2026

First Posted (Actual)

April 2, 2026

Study Record Updates

Last Update Posted (Actual)

April 2, 2026

Last Update Submitted That Met QC Criteria

March 27, 2026

Last Verified

March 1, 2026

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Temporomandibular Disorders (TMD)

Clinical Trials on Occlusal Splint

Subscribe